http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100870396-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate | 2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100870396-B1 |
| titleOfInvention | Oral Dosage Agents for Cardiovascular Disease |
| abstract | The present invention (a) a first pellet comprising a core layer and a enteric coating layer containing a thrombus inhibitor; And (b) a core pellet containing inert particles, an intermediate layer containing a cholesterol lowering agent, and an outer coating layer. The formulation of the present invention has an effect of reducing the risk of cardiovascular-related accidents as well as the improvement of medication compliance according to the mixed prescription.n n n n Aspirin, HMG-CoA Reductase Inhibitor, Simvastatin, Myocardial Infarction, Hyperlipidemia, Pellets |
| priorityDate | 2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.